Cernilton
- Generic Name
- Cernilton
Efficacy Study of a Standardized Pollen Extract Preparation (Cernilton) to Treat Inflammatory Chronic Prostatitis-Chronic Pelvic Pain Syndrome (CP-CPPS)
Phase 3
Completed
- Conditions
- Chronic Pelvic Pain SyndromeChronic Prostatitis
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-06-12
- Last Posted Date
- 2020-11-20
- Lead Sponsor
- University of Giessen
- Target Recruit Count
- 139
- Registration Number
- NCT00919893
- Locations
- 🇩🇪
Justus-Liebig-University, Giessen, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath